#1 Clinical Trials Search in Europe

Colestyramine

This article examines several clinical trials investigating the use of cholestyramine, a bile acid sequestrant, in various medical conditions. Cholestyramine has been studied for its potential benefits in managing hyperthyroidism, nonalcoholic fatty liver disease, and its interactions with other medications. These trials provide valuable insights into the drug’s efficacy, safety, and potential applications in different therapeutic areas.

Table of Contents

What is Cholestyramine?

Cholestyramine is a medication that belongs to a class of drugs called bile acid sequestrants. It is also known by the brand name Questran[1]. Cholestyramine comes in a powder form that is mixed with liquid and taken orally[1].

Medical Conditions Treated

Cholestyramine is used to treat various medical conditions, including:

  • Hyperthyroidism: An overactive thyroid gland that produces too much thyroid hormone[2].
  • Graves’ Disease: An autoimmune disorder that causes hyperthyroidism[2].
  • Nonalcoholic Fatty Liver Disease (NAFLD): A condition where excess fat accumulates in the liver of people who drink little or no alcohol[3].
  • Nonalcoholic Steatohepatitis (NASH): A more severe form of NAFLD that includes liver inflammation and damage[3].

How Cholestyramine Works

Cholestyramine works by binding to bile acids in the intestine and increasing their excretion in the feces. This mechanism has several effects:

  • Lowering cholesterol: By removing bile acids, the body is forced to use cholesterol to make more, which can lower blood cholesterol levels[3].
  • Reducing thyroid hormone levels: In hyperthyroidism, cholestyramine can help decrease the enterohepatic circulation (recycling) of thyroid hormones, leading to their increased excretion[2].
  • Altering bile acid pool: This can affect various metabolic processes in the body[4].

Dosage and Administration

The dosage of cholestyramine can vary depending on the condition being treated and the individual patient. Some common dosages used in clinical trials include:

  • 1 gram twice daily[2]
  • 2 grams twice daily[2]
  • 4 grams twice to four times daily[2]
  • 9 grams (containing 4 grams of cholestyramine) once daily[3]

Cholestyramine is typically mixed with water or another liquid before consumption. The exact mixing instructions may vary, so it’s important to follow your healthcare provider’s directions carefully.

Combination Therapies

Cholestyramine is often used in combination with other medications to enhance its effectiveness or to treat multiple aspects of a condition. Some combination therapies include:

  • Cholestyramine with methimazole and propranolol: This combination is used in the treatment of hyperthyroidism[2].
  • Cholestyramine with elobixibat: This combination is being studied for the treatment of nonalcoholic fatty liver disease[3].
  • Cholestyramine with metformin: This combination is being investigated for its effects on blood glucose levels and gut microbiome[4].

Side Effects and Tolerability

While cholestyramine is generally considered safe, it can have some side effects. The tolerability of the medication can vary among patients. Some studies have specifically looked at patient acceptability of cholestyramine, considering factors such as:

  • Taste
  • Texture
  • Appearance
  • Mixability[1]

These factors can affect how well patients adhere to their prescribed treatment regimen. If you experience any discomfort or side effects while taking cholestyramine, it’s important to discuss these with your healthcare provider.

Ongoing Research

Cholestyramine continues to be the subject of ongoing research to explore its potential benefits in various conditions. Some areas of current investigation include:

  • Effects on bile acid pool: Researchers are studying how changes in bile acid levels caused by cholestyramine might affect the body’s response to other medications, such as metformin[4].
  • Impact on gut microbiome: There is interest in understanding how cholestyramine might alter the composition of bacteria in the intestines[4].
  • Combination therapies for liver diseases: Studies are exploring the potential benefits of combining cholestyramine with other medications for treating conditions like nonalcoholic fatty liver disease[3].

As research continues, our understanding of cholestyramine’s benefits and optimal use may evolve. Always consult with your healthcare provider for the most up-to-date information about this medication.

Aspect Details
Primary Uses Lowering cholesterol, adjunctive therapy in hyperthyroidism, potential treatment for NAFLD
Mechanism of Action Binds to bile acids in intestine, prevents reabsorption, increases excretion of bound substances
Dosage Forms Powder, typically mixed with liquid before administration
Dosage Range 1-12 grams per day, depending on the condition and study protocol
Combination Therapies Studied with metformin, elobixibat, and standard hyperthyroidism treatments
Patient Considerations Taste and texture may affect acceptability; BASA scale used to assess patient experience
Potential Benefits Rapid reduction of thyroid hormone levels, improved lipid profiles, potential liver fat reduction
Areas of Research Drug interactions, efficacy in various conditions, optimal dosing strategies

FAQ

  • What is cholestyramine and how does it work? Cholestyramine is a bile acid sequestrant that binds to bile acids in the intestine, preventing their reabsorption. This action can help lower cholesterol levels and may have other therapeutic effects in various conditions.
  • In which medical conditions is cholestyramine being studied? Based on the clinical trials data, cholestyramine is being studied in hyperthyroidism, nonalcoholic fatty liver disease (NAFLD), and its interactions with other drugs like metformin and LOXO-783.
  • How is cholestyramine being used in hyperthyroidism treatment? Cholestyramine is being investigated as an adjunctive therapy to standard treatments for hyperthyroidism. It may help reduce thyroid hormone levels more rapidly by binding to these hormones in the intestine and increasing their excretion.
  • What are the potential benefits of combining cholestyramine with other medications? Combining cholestyramine with other medications may enhance their effects or alter their pharmacokinetics. For example, it's being studied in combination with elobixibat for NAFLD treatment and its impact on the absorption of drugs like LOXO-783.
  • Are there any challenges in using cholestyramine in clinical settings? One challenge is patient acceptability due to taste and texture issues. A study is evaluating different versions of a Bile Acid Sequestrant Acceptability (BASA) scale to assess and compare patient acceptability of cholestyramine and similar drugs.

Ongoing Clinical Trials on Colestyramine

  • Study on the Effect of Cholestyramine on Pollutant Levels in Obese Women Eligible for Bariatric Surgery

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Croatia Czechia Estonia France Germany +9

  • Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated drugs:
    Austria Belgium Bulgaria Croatia Denmark Ireland +7

  • Study on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated drugs:
    Austria Bulgaria Croatia Czechia Denmark France +10

Glossary

  • Cholestyramine: A bile acid sequestrant medication that binds to bile acids in the intestine, preventing their reabsorption. It is used to lower cholesterol levels and may have other therapeutic applications.
  • Bile acid sequestrant: A type of medication that binds to bile acids in the intestine, preventing their reabsorption and potentially lowering cholesterol levels.
  • Hyperthyroidism: A condition where the thyroid gland produces excessive amounts of thyroid hormones, leading to increased metabolism and various symptoms.
  • Nonalcoholic fatty liver disease (NAFLD): A condition characterized by the accumulation of fat in the liver of people who drink little or no alcohol, potentially leading to liver damage.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body over time.
  • Enterohepatic circulation: The circulation of substances, such as bile acids or thyroid hormones, between the liver and small intestine.
  • Bile Acid Sequestrant Acceptability (BASA) scale: A tool used to evaluate patient acceptability of bile acid sequestrants based on factors such as taste, texture, appearance, and mixability.
  • Thionamides: A class of antithyroid drugs used to treat hyperthyroidism by reducing the production of thyroid hormones.
  • MRI-PDFF: Magnetic Resonance Imaging Proton Density Fat Fraction, a non-invasive technique used to measure liver fat content.
  • LDL-C: Low-Density Lipoprotein Cholesterol, often referred to as 'bad' cholesterol, which can contribute to heart disease when levels are high.

References

  1. https://clinicaltrials.gov/study/NCT01062269
  2. https://clinicaltrials.gov/study/NCT00677469
  3. https://clinicaltrials.gov/study/NCT04235205
  4. https://clinicaltrials.gov/study/NCT04335526